Federico Ariel Augustovski

Summary

Country: Argentina

Publications

  1. doi request reprint Patient preferences for biologic agents in rheumatoid arthritis: a discrete-choice experiment
    Federico Augustovski
    Institute for Clinical Effectiveness and Health Policy IECS, Buenos Aires, Argentina
    Value Health 16:385-93. 2013
  2. pmc Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
    Don Husereau
    Institute of Health Economics, Edmonton, Canada
    Cost Eff Resour Alloc 11:6. 2013
  3. pmc Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
    Don Husereau
    Institute of Health Economics, Edmonton, Canada
    BMC Med 11:80. 2013
  4. pmc Lead versus lag-time trade-off variants: does it make any difference?
    Federico Augustovski
    Institute of Clinical Effectiveness and Health Policy, IECS, Dr Emilio Ravignani 2024, C1414CPV Buenos Aires, Argentina
    Eur J Health Econ 14:S25-31. 2013
  5. pmc Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina
    Adolfo Rubinstein
    IECS, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina
    Cost Eff Resour Alloc 7:10. 2009
  6. pmc Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina
    Adolfo Rubinstein
    Institute for Clinical Effectiveness and Health Policy IECS, Buenos Aires, Argentina
    BMC Public Health 10:627. 2010
  7. doi request reprint Economic evaluation guidelines in Latin America: a current snapshot
    Federico Augustovski
    Instituto de Efectividad Clínica y Sanitaria IECS, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, C1056ABH, Argentina
    Expert Rev Pharmacoecon Outcomes Res 10:525-37. 2010
  8. ncbi request reprint Childhood pneumococcal disease burden in Argentina
    Federico Ariel Augustovski
    Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina
    Rev Panam Salud Publica 25:423-30. 2009
  9. doi request reprint Universal coverage with rising healthcare costs; health outcomes research value in decision-making in Latin America
    Federico Augustovski
    Institute for Clinical Effectiveness and Health Policy, Dr Emilio Ravignani 2024 C1414CPT, Buenos Aires, Argentina
    Expert Rev Pharmacoecon Outcomes Res 11:657-9. 2011
  10. pmc Argentine valuation of the EQ-5D health states
    Federico Ariel Augustovski
    Institute for Clinical Effectiveness and Health Policy, School of Public Health, University of Buenos Aires School of Medicine, Buenos Aires, Argentina
    Value Health 12:587-96. 2009

Collaborators

Detail Information

Publications10

  1. doi request reprint Patient preferences for biologic agents in rheumatoid arthritis: a discrete-choice experiment
    Federico Augustovski
    Institute for Clinical Effectiveness and Health Policy IECS, Buenos Aires, Argentina
    Value Health 16:385-93. 2013
    ..To assess patients' preferences for rheumatoid-arthritis treatments with biologic agents using a discrete-choice experiment...
  2. pmc Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
    Don Husereau
    Institute of Health Economics, Edmonton, Canada
    Cost Eff Resour Alloc 11:6. 2013
    ..We encourage other journals and groups, to endorse CHEERS. The author team plans to review the checklist for an update in five years...
  3. pmc Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
    Don Husereau
    Institute of Health Economics, Edmonton, Canada
    BMC Med 11:80. 2013
    ..We encourage other journals and groups, to endorse CHEERS. The author team plans to review the checklist for an update in five years...
  4. pmc Lead versus lag-time trade-off variants: does it make any difference?
    Federico Augustovski
    Institute of Clinical Effectiveness and Health Policy, IECS, Dr Emilio Ravignani 2024, C1414CPV Buenos Aires, Argentina
    Eur J Health Econ 14:S25-31. 2013
    ..The traditional time trade-off (TTO) method has some problems in the valuation of health states considered worse than dead. The aim of our study is to compare two TTO variants that address this issue: lead-time and lag-time TTO...
  5. pmc Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina
    Adolfo Rubinstein
    IECS, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina
    Cost Eff Resour Alloc 7:10. 2009
    ..Use of this methodology in developing countries can make resource-allocation decisions less intuitive and more driven by evidence...
  6. pmc Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina
    Adolfo Rubinstein
    Institute for Clinical Effectiveness and Health Policy IECS, Buenos Aires, Argentina
    BMC Public Health 10:627. 2010
    ..6% of potential years of life lost (PYLL). The aim of the study was to estimate the burden of acute coronary heart disease (CHD) and stroke and the cost-effectiveness of preventative population-based and clinical interventions...
  7. doi request reprint Economic evaluation guidelines in Latin America: a current snapshot
    Federico Augustovski
    Instituto de Efectividad Clínica y Sanitaria IECS, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, C1056ABH, Argentina
    Expert Rev Pharmacoecon Outcomes Res 10:525-37. 2010
    ..In the near future we will be able to see if these documents were successfully used and applied for transparent and evidence-based decision making...
  8. ncbi request reprint Childhood pneumococcal disease burden in Argentina
    Federico Ariel Augustovski
    Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina
    Rev Panam Salud Publica 25:423-30. 2009
    ....
  9. doi request reprint Universal coverage with rising healthcare costs; health outcomes research value in decision-making in Latin America
    Federico Augustovski
    Institute for Clinical Effectiveness and Health Policy, Dr Emilio Ravignani 2024 C1414CPT, Buenos Aires, Argentina
    Expert Rev Pharmacoecon Outcomes Res 11:657-9. 2011
    ..It was the third biennial regional meeting in Latin America, the next one being in Buenos Aires (Argentina) in 2013...
  10. pmc Argentine valuation of the EQ-5D health states
    Federico Ariel Augustovski
    Institute for Clinical Effectiveness and Health Policy, School of Public Health, University of Buenos Aires School of Medicine, Buenos Aires, Argentina
    Value Health 12:587-96. 2009
    ..To develop a set of health state values based on EuroQol EQ-5D instrument for the Argentine general population...